DAISY CULVERHOUSE-PERRY: Open Payments
NPI 1740759299 · MORGANTOWN, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$964 in 63 payments from 13 companies in 2025. Trend: 2023 $314 · 2024 $1,067 · 2025 $964
Food & beverage: $964
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 32 | $367 |
| Alkermes, Inc. | 7 | $121 |
| Janssen Pharmaceuticals, Inc | 5 | $105 |
| Otsuka America Pharmaceutical, Inc. | 4 | $68 |
| Vanda Pharmaceuticals Inc. | 3 | $65 |
| Braeburn Inc. | 3 | $52 |
| Sage Therapeutics, LLC | 2 | $49 |
| Axsome Therapeutics, Inc. | 2 | $32 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $28 |
| Supernus Pharmaceuticals, Inc. | 1 | $25 |
Products named: VRAYLAR, ARISTADA, SPRAVATO, FANAPT, BRIXADI, ZURZUVAE, REXULTI, Auvelity.
Industry payments across WV — which companies pay providers there.
